Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Sznol

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Public Health Management and Practice : JPHMP|October 1, 2015
Characterizing the Business Skills of the Public Health Workforce: Practical Implications From the Public Health Workforce Interests and Needs Survey (PH WINS)Julie Kornfeld, Joshua Sznol, David Lee
Advances in Pharmacology (San Diego, Calif.)|September 11, 2012
Vertical pathway targeting in cancer therapyDavid Shahbazian, Joshua Sznol, Harriet M Kluger
Plos One|June 4, 2024
The persistent benefits of decreasing default pill counts for postoperative narcotic prescriptionsNathan Coppersmith, Joshua Sznol, Andrew Esposito, et al.
Journal of Translational Medicine|January 16, 2013
Vascularity of primary and metastatic renal cell carcinoma specimensSaadia A Aziz, Joshua Sznol, Adebowale Adeniran, et al.
Human Pathology|March 10, 2012
CD70 expression patterns in renal cell carcinomaLucia B Jilaveanu, Joshua Sznol, Saadia A Aziz, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Public Health Management and Practice : JPHMP|October 1, 2015
Characterizing the Business Skills of the Public Health Workforce: Practical Implications From the Public Health Workforce Interests and Needs Survey (PH WINS)Julie Kornfeld, Joshua Sznol, David Lee
Advances in Pharmacology (San Diego, Calif.)|September 11, 2012
Vertical pathway targeting in cancer therapyDavid Shahbazian, Joshua Sznol, Harriet M Kluger
Plos One|June 4, 2024
The persistent benefits of decreasing default pill counts for postoperative narcotic prescriptionsNathan Coppersmith, Joshua Sznol, Andrew Esposito, et al.
Journal of Translational Medicine|January 16, 2013
Vascularity of primary and metastatic renal cell carcinoma specimensSaadia A Aziz, Joshua Sznol, Adebowale Adeniran, et al.
Human Pathology|March 10, 2012
CD70 expression patterns in renal cell carcinomaLucia B Jilaveanu, Joshua Sznol, Saadia A Aziz, et al.
Pageof 1